MHC class II proteins and disease: a structural perspective

被引:316
作者
Jones, EY
Fugger, L
Strominger, JL
Siebold, C
机构
[1] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England
[2] Aarhus Univ Hosp, Dept Clin Immunol, DK-8200 Aarhus N, Denmark
[3] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Human Immunol Unit, Oxford OX3 9DS, England
[4] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
基金
英国医学研究理事会;
关键词
D O I
10.1038/nri1805
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MHC class II molecules on the surface of antigen-presenting cells display a range of peptides for recognition by the T-cell receptors of CD4(+) T helper cells. Therefore, MHC class II molecules are central to effective adaptive immune responses, but conversely, genetic and epidemiological data have implicated these molecules in the pathogenesis of autoimmune diseases. Indeed, the strength of the associations between particular MHC class II alleles and disease render them the main genetic risk factors for autoimmune disorders such as type 1 diabetes. Here, we discuss the insights that the crystal structures of MHC class II molecules provide into the molecular mechanisms by which sequence polymorphisms might contribute to disease susceptibility.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 74 条
[41]   Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups [J].
Mignot, E ;
Lin, L ;
Rogers, W ;
Honda, Y ;
Qiu, XH ;
Lin, XY ;
Okun, M ;
Hohjoh, H ;
Miki, T ;
Hsu, SH ;
Leffell, MS ;
Grumet, FC ;
Fernandez-Vina, M ;
Honda, M ;
Risch, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :686-699
[42]   Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease [J].
Molberg, O ;
Mcadam, SN ;
Körner, R ;
Quarsten, H ;
Kristiansen, C ;
Madsen, L ;
Fugger, L ;
Scott, H ;
Norén, O ;
Roepstorff, P ;
Lundin, KEA ;
Sjöström, H ;
Sollid, LM .
NATURE MEDICINE, 1998, 4 (06) :713-717
[43]   Hypocretin (orexin) deficiency in human narcolepsy [J].
Nishino, S ;
Ripley, B ;
Overeem, S ;
Lammers, GJ ;
Mignot, E .
LANCET, 2000, 355 (9197) :39-40
[44]   Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans [J].
Oksenberg, JR ;
Barcellos, LF ;
Cree, BAC ;
Baranzini, SE ;
Bugawan, TL ;
Khan, O ;
Lincoln, RR ;
Swerdlin, A ;
Mignot, E ;
Lin, L ;
Goodin, D ;
Erlich, HA ;
Schmidt, S ;
Thomson, G ;
Reich, DE ;
Pericak-Vance, MA ;
Haines, JL ;
Hauser, SL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (01) :160-167
[45]   SELECTION FOR T-CELL RECEPTOR V-BETA-D-BETA-J-BETA GENE REARRANGEMENTS WITH SPECIFICITY FOR A MYELIN BASIC-PROTEIN PEPTIDE IN BRAIN-LESIONS OF MULTIPLE-SCLEROSIS [J].
OKSENBERG, JR ;
PANZARA, MA ;
BEGOVICH, AB ;
MITCHELL, D ;
ERLICH, HA ;
MURRAY, RS ;
SHIMONKEVITZ, R ;
SHERRITT, M ;
ROTHBARD, J ;
BERNARD, CCA ;
STEINMAN, L .
NATURE, 1993, 362 (6415) :68-70
[46]   Clinical aspects of narcolepsy-cataplexy across ethnic groups [J].
Okun, ML ;
Lin, L ;
Pelin, Z ;
Hong, SC ;
Mignot, E .
SLEEP, 2002, 25 (01) :27-35
[47]   A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains [J].
Peyron, C ;
Faraco, J ;
Rogers, W ;
Ripley, B ;
Overeem, S ;
Charnay, Y ;
Nevsimalova, S ;
Aldrich, M ;
Reynolds, D ;
Albin, R ;
Li, R ;
Hungs, M ;
Pedrazzoli, M ;
Padigaru, M ;
Kucherlapati, M ;
Fan, J ;
Maki, R ;
Lammers, GJ ;
Bouras, C ;
Kucherlapati, R ;
Nishino, S ;
Mignot, E .
NATURE MEDICINE, 2000, 6 (09) :991-997
[48]   Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: Importance of proline spacing and glutamine deamidation [J].
Qiao, SW ;
Bergseng, E ;
Molberg, O ;
Jung, G ;
Fleckenstein, B ;
Sollid, LM .
JOURNAL OF IMMUNOLOGY, 2005, 175 (01) :254-261
[49]  
Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.3.CO
[50]  
2-K